The global Antimicrobial Susceptibility Testing Market is gaining importance as healthcare providers and diagnostic laboratories increasingly focus on identifying effective treatments for bacterial infections. Antimicrobial susceptibility testing (AST) helps determine how microorganisms respond to different antimicrobial agents, supporting healthcare professionals in selecting appropriate treatment options and addressing the growing challenge of antimicrobial resistance.
According to Fortune Business Insights, the Antimicrobial Susceptibility Testing Market size was valued at USD 4.14 billion in 2025. The market is projected to grow from USD 4.42 billion in 2026 to USD 7.55 billion by 2034, exhibiting a CAGR of 6.9% during the forecast period.
The increasing prevalence of antimicrobial-resistant infections is one of the major factors supporting the growth of the Antimicrobial Susceptibility Testing Market. The inappropriate or excessive use of antimicrobial medicines has contributed to the development of resistant microorganisms, making infection management increasingly challenging.
AST provides important information about the susceptibility or resistance of pathogens to specific antimicrobial drugs. As healthcare institutions place greater emphasis on responsible antimicrobial use, demand for accurate susceptibility testing is expected to increase.
Healthcare providers are increasingly seeking diagnostic methods that can deliver reliable results within shorter timeframes. Rapid testing can support faster clinical decision-making and may help healthcare professionals select appropriate therapies sooner.
Advances in laboratory automation, microbiology systems, and diagnostic technologies are contributing to improvements in testing workflows. Automated systems can reduce manual procedures, improve laboratory efficiency, and support standardized testing processes.
For detailed market insights : https://www.fortunebusinessinsights.com/antimicrobial-susceptibility-testing-market-107735
The Antimicrobial Susceptibility Testing Market can be analyzed based on test type, including manual susceptibility testing methods, automated testing systems, and other advanced approaches.
Manual methods remain important in many clinical and research laboratories because of their established use and relatively straightforward procedures. However, automated testing systems are gaining attention because they can process multiple samples efficiently while reducing manual intervention.
The increasing adoption of automated microbiology platforms is expected to create opportunities for manufacturers developing advanced AST solutions.
AST methods include disk diffusion, broth dilution, agar dilution, and other testing techniques. Each method has specific applications depending on the microorganism being evaluated, laboratory resources, and testing requirements.
Disk diffusion remains a widely recognized approach because it is relatively simple and cost-effective. Broth-based methods can provide quantitative information about antimicrobial activity and are particularly useful when determining minimum inhibitory concentrations.
Continued technological development is expected to improve the efficiency and reliability of these methods while supporting their use across different laboratory settings.
Antimicrobial susceptibility testing is used across clinical diagnostics, pharmaceutical and biotechnology research, academic institutions, and other healthcare applications.
Clinical diagnostics represent a significant application area because healthcare professionals require information about pathogen susceptibility when managing infectious diseases. Diagnostic laboratories also use AST to support routine microbiological testing and infection management.